Pfizer : PFE

All Pfizer Articles

1515 Articles

Jon C. Ogg | Dec 11, 2018 at 9:10 AM EST

Top Analyst Upgrades and Downgrades: Apptio, AT&T, Bain Capital, Comerica, First Solar, Palo Alto, Pfizer, Travelers, Ulta Beauty and More

The included top analyst upgrades, downgrades and initiations seen on Tuesday Apptio, AT&T, Bain Capital, Comerica, First Solar, Palo Alto…

Chris Lange | Nov 28, 2018 at 9:00 AM EST

Short Sellers Hike Their Bets in Major Pharma Stocks

The November 15 short interest data have been compared with the previous figures, and short interest in most of these…

Jon C. Ogg | Nov 27, 2018 at 6:45 AM EST

High Debt Maturities Bring Risk to the Endless Stock Buyback Addiction After 2018

Now that 2018 is nearing an end, it is a serious time for investors to start thinking about expectations in 2019…

Lee Jackson | Nov 26, 2018 at 7:00 AM EST

With Long Bull Market Almost Over, Time to Rotate to Safety and Income

24/7 Wall St. screened the Merrill Lynch research database for stocks rated Buy that pay a dividend and have the…

Chris Lange | Nov 12, 2018 at 10:10 AM EST

Short Sellers Pull Back on Major Pharma — With 1 Big Exception

The October 31 short interest data have been compared with the previous figures, and short interest in most of these…

Jon C. Ogg | Nov 8, 2018 at 12:45 PM EST

New Erectile Dysfunction Treatment Likely to Face Stiff Competition If Approved

The demand for drugs to treat erectile dysfunction has risen to meet the needs of an aging population and to…

Paul Ausick | Nov 7, 2018 at 4:01 PM EST

UnitedHealth, Caterpillar Launch the Dow Higher Wednesday

Caterpillar, UnitedHealth, Microsoft, and Pfizer lifted the down to 500-point gain Wednesday.

Chris Lange | Nov 6, 2018 at 11:50 AM EST

Nektar Therapeutics and Pfizer Team Up in Cancer Collaboration

Nektar shares dipped on Tuesday after the company announced that it would be collaborating with Pfizer to evaluate several combination…

Paul Ausick | Nov 2, 2018 at 4:01 PM EDT

Apple, Intel Tank the Dow Friday

Apple, Intel, Pfizer, and Merck were the worst performing Dow stocks on Friday.

Jon C. Ogg | Nov 1, 2018 at 8:55 AM EDT

Top Analyst Upgrades and Downgrades: American Eagle, Facebook, Nutrisystem, Pfizer, Roku, SeaWorld, Valero, Zynga and More

The top analyst upgrades, downgrades and initiations seen on Thursday included American Eagle Outfitters, Facebook, Nutrisystem, Pfizer, Roku, SeaWorld, Valero…

Chris Lange | Oct 30, 2018 at 8:40 AM EDT

Why Pfizer Is Tripping Over Itself With Earnings

Pfizer reported mixed quarterly results before the markets opened on Tuesday and shares retreated in the premarket.

Chris Lange | Oct 29, 2018 at 11:25 AM EDT

What to Watch For When Pfizer Reports Tuesday Morning

Pfizer is scheduled to release its third-quarter financial results before the markets open on Tuesday.

Chris Lange | Oct 28, 2018 at 7:20 AM EDT

Apple, Exxon, Pfizer and More Dow Earnings to Watch For

24/7 Wall St. has put together a preview of the Dow companies scheduled to report their quarterly results this week.…

Chris Lange | Oct 25, 2018 at 9:00 AM EDT

Major Pharma Short Sellers Hike Their Bets

The October 15 short interest data have been compared with the previous figures, and short interest in most of these…

Lee Jackson | Oct 25, 2018 at 7:10 AM EDT

Why Large Cap Pharmaceuticals Will Hold Up in a Bear Market

These four top pharmaceutical companies have longstanding franchises with huge sales and revenues, and their dividend-paying stocks look like outstanding choices…

1 … 33 34 35 36 37 … 101

Pfizer : PFE

All Pfizer Articles

Top Analyst Upgrades and Downgrades: Apptio, AT&T, Bain Capital, Comerica, First Solar, Palo Alto, Pfizer, Travelers, Ulta Beauty and More

Short Sellers Hike Their Bets in Major Pharma Stocks

High Debt Maturities Bring Risk to the Endless Stock Buyback Addiction After 2018

With Long Bull Market Almost Over, Time to Rotate to Safety and Income

Short Sellers Pull Back on Major Pharma — With 1 Big Exception

New Erectile Dysfunction Treatment Likely to Face Stiff Competition If Approved

UnitedHealth, Caterpillar Launch the Dow Higher Wednesday

Nektar Therapeutics and Pfizer Team Up in Cancer Collaboration

Apple, Intel Tank the Dow Friday

Top Analyst Upgrades and Downgrades: American Eagle, Facebook, Nutrisystem, Pfizer, Roku, SeaWorld, Valero, Zynga and More

Why Pfizer Is Tripping Over Itself With Earnings

What to Watch For When Pfizer Reports Tuesday Morning

Apple, Exxon, Pfizer and More Dow Earnings to Watch For

Major Pharma Short Sellers Hike Their Bets

Why Large Cap Pharmaceuticals Will Hold Up in a Bear Market

Why High-Earning Pilots Should Delay 401(k) Roth Conversions Until After Mandatory Retirement at 65

The $1,000 Hidden Tax on Every $10,000 Invested in This NVIDIA ETF

Everyone’s Chasing The Villages. Smart Retirees Are Quietly Buying Here Instead

Why High-Earning Pilots Should Delay 401(k) Roth Conversions Until After Mandatory Retirement at 65

Everyone's Chasing The Villages. Smart Retirees Are Quietly Buying Here Instead

Why High-Earning Pilots Should Delay 401(k) Roth Conversions Until After Mandatory Retirement at 65

The $1,000 Hidden Tax on Every $10,000 Invested in This NVIDIA ETF

Pfizer : PFE

All Pfizer Articles

Top Analyst Upgrades and Downgrades: Apptio, AT&T, Bain Capital, Comerica, First Solar, Palo Alto, Pfizer, Travelers, Ulta Beauty and More

Short Sellers Hike Their Bets in Major Pharma Stocks

High Debt Maturities Bring Risk to the Endless Stock Buyback Addiction After 2018

With Long Bull Market Almost Over, Time to Rotate to Safety and Income

Short Sellers Pull Back on Major Pharma — With 1 Big Exception

New Erectile Dysfunction Treatment Likely to Face Stiff Competition If Approved

UnitedHealth, Caterpillar Launch the Dow Higher Wednesday

Nektar Therapeutics and Pfizer Team Up in Cancer Collaboration

Apple, Intel Tank the Dow Friday

Top Analyst Upgrades and Downgrades: American Eagle, Facebook, Nutrisystem, Pfizer, Roku, SeaWorld, Valero, Zynga and More

Why Pfizer Is Tripping Over Itself With Earnings

What to Watch For When Pfizer Reports Tuesday Morning

Apple, Exxon, Pfizer and More Dow Earnings to Watch For

Major Pharma Short Sellers Hike Their Bets

Why Large Cap Pharmaceuticals Will Hold Up in a Bear Market

Why High-Earning Pilots Should Delay 401(k) Roth Conversions Until After Mandatory Retirement at 65

The $1,000 Hidden Tax on Every $10,000 Invested in This NVIDIA ETF

Everyone’s Chasing The Villages. Smart Retirees Are Quietly Buying Here Instead

Featured Reads

Why High-Earning Pilots Should Delay 401(k) Roth Conversions Until After Mandatory Retirement at 65

Everyone's Chasing The Villages. Smart Retirees Are Quietly Buying Here Instead